Vanguard Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.5B | Buy |
|
|||||
|
2023
Q2 | $2.22B | Sell |
|
|||||
|
2023
Q1 | $2.35B | Buy |
|
|||||
|
2022
Q4 | $2.42B | Sell |
|
|||||
|
2022
Q3 | $1.32B | Buy |
|
|||||
|
2022
Q2 | $1.67B | Buy |
|
|||||
|
2022
Q1 | $2.14B | Buy |
|
|||||
|
2021
Q4 | $2.17B | Buy |
|
|||||
|
2021
Q3 | $2.19B | Buy |
|
|||||
|
2021
Q2 | $1.87B | Sell |
|
|||||
|
2021
Q1 | $1.89B | Buy |
|
|||||
|
2020
Q4 | $1.46B | Buy |
|
|||||
|
2020
Q3 | $1.5B | Buy |
|
|||||
|
2020
Q2 | $987M | Buy |
|
|||||
|
2020
Q1 | $520M | Buy |
|
|||||
|
2019
Q4 | $619M | Buy |
|
|||||
|
2019
Q3 | $463M | Buy |
|
|||||
|
2019
Q2 | $399M | Sell |
|
|||||
|
2019
Q1 | $446M | Buy |
|
|||||
|
2018
Q4 | $300M | Buy |
|
|||||
|
2018
Q3 | $290M | Buy |
|
|||||
|
2018
Q2 | $236M | Buy |
|
|||||
|
2018
Q1 | $194M | Buy |
|
|||||
|
2017
Q4 | $197M | Buy |
|
|||||
|
2017
Q3 | $167M | Buy |
|
|||||
|
2017
Q2 | $154M | Buy |
|
|||||
|
2017
Q1 | $188M | Buy |
|
|||||
|
2016
Q4 | $198M | Buy |
|
|||||
|
2016
Q3 | $216M | Buy |
|
|||||
|
2016
Q2 | $174M | Buy |
|
|||||
|
2016
Q1 | $163M | Buy |
|
|||||
|
2015
Q4 | $207M | Buy |
|
|||||
|
2015
Q3 | $177M | Buy |
|
|||||
|
2015
Q2 | $299M | Buy |
|
|||||
|
2015
Q1 | $143M | Buy |
|
|||||
|
2014
Q4 | $51.6M | Buy |
|
|||||
|
2014
Q3 | $21.7M | Buy |
|
|||||
|
2014
Q2 | $26.5M | Buy |
|
|||||
|
2014
Q1 | $19M | Buy |
|
|||||
|
2013
Q4 | $7.46M | Buy |
|
|||||
|
2013
Q3 | $2.92M | Buy |
|
|||||
|
2013
Q2 | $1.87M | Buy |
|